Arthritis Studies: Enrolling NOW!

Below is a list of all current studies. It would be a great experience to work with you on an Arthritis research study. Benefits of volunteering include compensation for time and travel, free medical visits, and being part of future treatments and medical innovation. Call 417.883.7889 or email us and one of our friendly staff will guide you through the next steps.

Study #415 From stiff, painful and inflamed joints to fatigue and weight loss, the symptoms associated with active rheumatoid arthritis can seriously impact one’s quality of life

We are currently conducting a research study investigating the comparative safety and efficacy of investigational and approved RA drugs. To participate in this clinical research study , you must meet all study criteria, including the following:

  • You are 18 years of age or older,
  • You have been diagnosed with moderate to severe rheumatoid arthritis,
  • You are currently taking methotrxate,
  • You are not adequately responding to current treatment, and
  • You are willing to follow a study plan, attend routinely scheduled study visits and complete a study dosing diary for approximately 12 months.

If you are eligible for participation, you will be randomized to receive one of three study medication combinations and all study-related medical care at no cost to you. For more information please contact Clinvest 417.883.7889 or email us.

Study #412- 20110186
As part of a nationwide study . Dr Anne Winkler and Clinvest are seeking volunteers who have well-controlled moderate to severe RA. The purpose of this study is to document the effectiveness of Enbrel + Methotrexate compared to Enbrel injections alone , or Methotrexate alone.

If you are:

  • You are 18 years of age or older,
  • You have been diagnosed with moderate to severe rheumatoid arthritis,

For more information please contact Clinvest 417.883.7889 or email us.

Study #411 Research Study for People with Moderate to Severe RA Who Also Have Cardiac Risk Factors

As part of a nationwide study, Dr. Winkler and Clinvest are seeking volunteers who have moderate to severe RA, plus cardiac risk factors, in the Springfield area.  The purpose of this study is to document the safety of Xeljanz (taken twice daily), compared to Humira (given as an injection every-other-week).

If you are:

  • At least 50 years old
  • Have been diagnosed with Rheumatoid Arthritis
  • Experience moderate to severe pain associated with your RA

Please consider contacting the research professionals at Clinvest to find out more information. Clinvest is conducting this study in cooperation with Rheumatologist, Dr. Anne Winkler.

For more information please contact Clinvest 417.883.7889 or email us.